Beats Medical

Re-imagine clinical development through digital evidence generation with Beats Medical. Beats Medical are the worlds leaders in digital assessments, therapies and biomarkers for Central Nervous System Conditions and Rare Disease. Our patented platform technology, Colbolt, provides frictionless access to gold standard assessments and therapies in real time, with an embedded digital biomarkers focus to help our partners unlock the breakthrough therapies of the future. Through the Beats Medical Colbolt platform, pharma partners can seamlessly integrate digital assessments and measures across the clinical development value chain, from the early stages of the R&D pipeline, to post-commercialization real world data collection. Our...

Objective digital assessments with enhanced sensitivity,individually tailored digital therapies,embedded digital biomarkers to unlock breakthrough therapies ,central nervous system conditions,rare disease,pharma r&d transformation ,cross-platform harmonisation ,frictionless delivery requiring no additional hardware,and patented platform technology,colbolt

Beats medical operates in the Medical device industry.

Beats medical's revenue is 11m - 100m

Beats medical has 11 - 50 employees.